Ventyx Biosciences Announces $100 Million Private Placement of Common Stock
Gross proceeds of the private placement are expected to be approximately $100 million, before deducting placement agent fees and other expenses.
- Gross proceeds of the private placement are expected to be approximately $100 million, before deducting placement agent fees and other expenses.
- The private placement is expected to close on March 11, 2024, subject to the satisfaction of customary closing conditions.
- With the proceeds from the private placement, Ventyx expects to extend its cash runway into at least the second half of 2026.
- Ventyx has agreed to file a registration statement with the Securities and Exchange Commission registering the resale of the shares of common stock issued in this private placement.